Insulatard Insulin is an intermediate-acting type of human insulin used to control high blood sugar (hyperglycemia) in people with diabetes mellitus.

Here’s a breakdown of its key details:

Description:
Clear, colorless liquid injection available in various vial sizes
Contains human insulin mixed with protamine, a protein that delays its absorption

Active ingredient:
Human insulin (isophane)

Therapeutic Category:
Antidiabetic-agent

How it works:
Insulatard slowly releases insulin over a period of about 24 hours, helping to control blood sugar levels throughout the day.
Its peak effect typically occurs 4-12 hours after injection and can last for up to 24 hours.

Indications:
Treatment of type 1 and type 2 diabetes mellitus

Contraindications:
Hypoglycemia (low blood sugar)
Hypersensitivity to insulin or any of the excipients in the formulation
Diabetic ketoacidosis (serious complication of diabetes)

Dosage:
Individualized based on the patient’s blood sugar levels, type of diabetes, and other factors
Injected subcutaneously (under the skin) in the abdomen, thigh, buttock, or upper arm
Usually not recommended for intravenous (into a vein) or intramuscular (into a muscle) injection

Added information:
Requires proper handling and storage (cool, dry place, away from light and heat)
Monitor blood sugar levels regularly
Risk of hypoglycemia if dosage is too high or if meals are missed
May interact with other medications (consult your doctor)

Possible side effects:
Injection site reactions (redness, pain, swelling)
Hypoglycemia (sweating, dizziness, shakiness, headache)
Lipodystrophy (changes in fat tissue at the injection site)
Allergic reactions (rare)

Storage:
Unopened vials: store in a refrigerator (2-8°C)
Opened vials: store at room temperature (up to 25°C) for up to 4 weeks
Do not freeze.

Product Substitute:
Other brands of NPH human insulin such as Insugen-N, Wosulin-N, etc.

Manufacturer/Marketer:
Novo Nordisk

Country of Origin:
Denmark